VALIRX
Valirx Plc, an investment holding company, engages in the research and development of oncology therapeutics and diagnostics in the United Kingdom. The company principally offers VAL 101 that acts to shut down the Bcl-2 gene, a proto-oncogene. It develops human papilloma virus diagnostic products based on the Nucleosomics, a platform for non-invasive tests for early cancer diagnosis based on epigenetic signal changes associated with malignancy; and HyperGenomics, a platform for differential diagnostic and prognostic tests in cancer, as well as testing for personalized medicine. The company also develops GeneICE compounds, which treat various diseases by acting to shut down harmful genes and prevent their expression. Valirx Plc is based in London, the United Kingdom.
VALIRX
Social Links:
Industry:
Biotechnology Health Diagnostics Oncology Therapeutics
Founded:
2000-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.valirx.com
Total Employee:
1+
Status:
Active
Contact:
+44 (0)203 0084415
Email Addresses:
[email protected]
Total Funding:
800 K GBP
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon Google Tag Manager Google Analytics Google Maps Content Delivery Network LetsEncrypt SSL By Default
Similar Organizations
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Instadiagnostics
Instadiagnostics Inc., is developing a rapid, quantitative, point-of-care (POC) diagnostic platform.
NBE-Therapeutics
NBE-Therapeutics is a biotech company that develops oncology treatments for cancer patients.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Raze Therapeutics
Raze Therapeutics, Inc., a biotechnology company, engages in the discovery and development of oncology therapeutics.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Visterra
Visterra researches on and develops therapeutic and diagnostic products for the treatment of infectious diseases.
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2008-07-14 | ValiPharma | ValiPharma acquired by ValiRX | N/A |
| 2008-07-14 | Chronos Therapeutics | Chronos Therapeutics acquired by ValiRX | N/A |
Key Employee Changes
| Date | New article |
|---|---|
| 2022-09-08 | ValiRx Names Catherine Tralau-Stewart as Interim Chief Scientific Officer |
Official Site Inspections
http://www.valirx.com Semrush global rank: 9.45 M Semrush visits lastest month: 379
- Host name: 77.68.91.156
- IP address: 77.68.91.156
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "ValiRX"
Accelerating Biomedical Innovation | Drug Development | ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid …See details»
ValiRX - Crunchbase Company Profile & Funding
Valirx Plc, an investment holding company, engages in the research and development of oncology therapeutics and diagnostics in the United Kingdom. …See details»
Early-Stage Drug Development - How We Work | ValiRx PLC
ValiRx is a drug development company, which focuses on the translation of scientific innovation into clinical candidates for cancer, related conditions and women’s health. Our specialised …See details»
Corporate Governance | ValiRx PLC
ValiRx plc is a member of the Quoted Companies Alliance, the independent membership organisation that champions the interests of small to mid-size quoted companies. ValiRx plc is …See details»
ValiRx Company Profile 2024: Stock Performance & Earnings
ValiRx PLC is a UK-based biopharmaceutical company. It mainly engages in developing technologies and products in oncology therapeutics and diagnostics. The area of focus for the …See details»
Org Chart ValiRx - The Official Board
The organizational chart of ValiRx displays its 9 main executives including Mark EcclestonSee details»
Company ValiRx plc - MarketScreener.com
Aug 31, 2006 · ValiRx plc is a life science company. The Company is focused on early-stage cancer therapeutics and women's health. The Company provides the scientific, financial and …See details»
ValiRx plc - AnnualReports.com
ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company's lead drug candidates …See details»
Strategy & Vision | ValiRx PLC
Our therapeutic focus prioritises cancer, related conditions and women’s health. Our pipeline is enriched by robust partnerships with academia and industry, fuelled by our intellectual and …See details»
ValiRx Plc Company Profile - Overview - GlobalData
ValiRx Plc (ValiRx) is a life science company that develops therapeutics for the treatment of clinical stage cancer. The company’s pipeline products include VAL201 is for the treatment of …See details»
ValiRx plc: Shareholders Board Members Managers and Company …
Aug 31, 2006 · ValiRx plc is a life science company. The Company is focused on early-stage cancer therapeutics and women's health. The Company provides the scientific, financial and …See details»
ValiRX - Contacts, Employees, Board Members, Advisors & Alumni
Valirx Plc, an investment holding company, engages in the research and development of oncology therapeutics and diagnostics in the UnitedSee details»
Valirx Company Profile - Office Locations, Competitors, Revenue
Oct 14, 2024 · ValiRx, a biopharmaceutical company, engages in developing technologies and products in oncology therapeutics and diagnostics. Its proprietary GeneICE technology …See details»
ValiRx - VentureRadar
ValiRx is a biotechnology oncology focused company specialising in developing novel treatments for cancer and associated biomarkers.See details»
Regulatory News | ValiRx PLC
Click here to view the regulatory news alerts of interest to existing and potential shareholders, including news about drug developments and Cytolytix.See details»
ValiPharma - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +44 (0)203 0084415 Cronos Therapeutics, Ltd., a biopharmaceutical company, develops therapeutics and diagnostics based on epigenomics for …See details»
ValiRx plc - PubMed
ValiBio is developing low-cost, rapid, high-throughput, noninvasive screening tests for the early detection, differential diagnosis and prognosis of cancer using its patented Hypergenomicsâ„¢ …See details»
ValiRx 2023: A year in review
Dec 19, 2023 · From the launch of our subsidiary company Inaphaea BioLabs, to announcing new additions to the team and key strategic partnerships, it has been a busy and exciting year of …See details»
ValiRx strikes deal with Ambrose Healthcare to license late-stage ...
Dec 5, 2023 · ValiRx Plc, a life science company focusing on cancer therapeutics and women’s health, has announced that ValiRx subsidiary, ValiSeek Ltd, has entered into an exclusive …See details»
Corporate Social Responsibility | ValiRx PLC
ValiRx is committed to operating responsibly and establishing high ethical standards across our company. Acting with integrity is critical to securing our long-term success. Read about our …See details»